These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 909738)

  • 1. [De novo purine biosynthesis. In vitro measurement in hyperuricemia (author's transl)].
    Chanard J; Kamoun P; Pleau JM; Brami M; Brunois JP; Funck-Brentano JL
    Nouv Presse Med; 1977 Sep; 6(29):2579-82. PubMed ID: 909738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine biosynthesis de novo by lymphocytes in gout.
    Kamoun P; Chanard J; Brami M; Funck-Brentano JL
    Clin Sci Mol Med; 1978 Jun; 54(6):595-601. PubMed ID: 657727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the measurement of de novo biosynthesis of purine bases in hyperuricemia].
    Chanard J; Kamoun P; Plèau JM; Brami M; Funck-Brentano JL
    Ann Med Interne (Paris); 1977; 128(6-7):589-91. PubMed ID: 921118
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hyperuricemia and renal insufficiency.
    Foreman JW; Yudkoff M
    Child Nephrol Urol; 1990; 10(2):115-8. PubMed ID: 2253250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of hyperuricemia].
    Ryckewaert A
    Presse Med (1893); 1968 Dec; 76(49):2319-22. PubMed ID: 5260909
    [No Abstract]   [Full Text] [Related]  

  • 9. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 10. [Benziodarone in hyperuricemia due to renal insufficiency].
    Boine L
    Minerva Med; 1973 Jan; 64(4):157-9. PubMed ID: 4568713
    [No Abstract]   [Full Text] [Related]  

  • 11. Purine synthesis de novo in lymphocytes from patients with gout.
    Gordon RB; Counsilman AC; Cross SM; Emmerson BT
    Clin Sci (Lond); 1982 Nov; 63(5):429-35. PubMed ID: 7116783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of allopurinol on the indicators of immunity in podagra and experimental hyperuricemia].
    Siniachenko OV; Nikolenko IuI; Diadyk AI; Bortnik VA; Okushko RV
    Revmatologiia (Mosk); 1991; (1):12-5. PubMed ID: 2068454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Brosh S; Boer P; Kupfer B; de Vries A; Sperling O
    J Clin Invest; 1976 Aug; 58(2):289-97. PubMed ID: 956368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of hyperuricemia with allopurinol].
    Hood B; Olander R; Sjöberg KH; Orndahl G
    Lakartidningen; 1968 Feb; 65(6):574-82. PubMed ID: 5723559
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is asymptomatic hyperuricemia in kidney-failure patients in need of therapy?].
    Stiefel M; Verberckmoes R; Ritz E
    Dtsch Med Wochenschr; 1989 Jun; 114(24):964-8. PubMed ID: 2659307
    [No Abstract]   [Full Text] [Related]  

  • 19. [Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricemias].
    Potaux L; Aparicio M; Maurel C; Ruedas ME; Martin-Dupont Cl
    Nouv Presse Med; 1975 Apr; 4(15):1109-12. PubMed ID: 1094413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.